文献速递毛发、甲与色素性疾病皮肤肿瘤皮肤感染

光生物调节(PBM)第二部分:皮肤科临床应用

Photobiomodulation CME part II: Clinical applications in dermatology.
PubMed 文献 · J Am Acad Dermatol · 2024-02-01

光生物调节(PBM)是皮肤科新兴治疗手段,利用红光(620-700 nm)和近红外光(700-1440 nm)光谱,常通过低强度激光或发光二极管实施。研究显示PBM可有效治疗癌症治疗继发状况、脱发、溃疡、单纯疱疹病毒、痤疮、皮肤年轻化、伤口和瘢痕,具有无创、经济、便捷和安全性好的优点,可作为药物等治疗的替代或辅助。皮肤科医生需了解PBM的诊室应用并指导患者正确使用家用设备,同时未来需临床试验制定标准化推荐。

要点

  • PBM使用红光和近红外光谱,常通过低强度激光或LED实施。
  • PBM可治疗脱发、溃疡、痤疮、伤口、瘢痕等多种皮肤问题。
  • PBM无创、经济、便捷且安全性好,可作替代或辅助治疗。

核心结论

  • PBM是皮肤科新兴治疗手段,具有无创、经济、便捷和安全性好的优点,可作替代或辅助治疗。

研究设计与样本

  • 本文为综述,概述PBM在皮肤科的临床应用,未报告系统检索范围。

主要发现

  • PBM可有效治疗癌症治疗继发状况、脱发、溃疡、单纯疱疹病毒、痤疮、皮肤年轻化、伤口和瘢痕。
  • PBM波长在不同皮肤类型、种族和民族中可诱导不同的生物学效应。

关键数值与推荐

  • PBM使用红光(620-700 nm)和近红外光(700-1440 nm)光谱,常通过低强度激光或发光二极管实施。

临床怎么用

  • 皮肤科医生应了解PBM的诊室应用,并指导患者正确使用家用设备以管理安全性和期望。
  • 对肤色较深患者进行PBM治疗时,需根据其皮肤类型进行适当咨询。

局限性

  • 未来需要临床试验以制定针对不同疾病和皮肤类型的标准化推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Photobiomodulation (PBM) is an emerging treatment modality in dermatology with increasing office and home-based use. PBM is the use of various light sources in the red light (620-700 nm) and near-infrared (700-1440 nm) spectrum as a form of light therapy. PBM is often administered through low-level lasers or light-emitting diodes. Studies show that PBM can be used effectively to treat conditions secondary to cancer therapies, alopecia, ulcers, herpes simplex virus, acne, skin rejuvenation, wounds, and scars. PBM offers patients many benefits compared to other treatments. It is noninvasive, cost-effective, convenient for patients, and offers a favorable safety profile. PBM can be used as an alternative or adjuvant to other treatment modalities including pharmacotherapy. It is important for dermatologists to gain a better clinical understanding of PBM for in-office administration and to counsel patients on proper application for home-use devices to best manage safety and expectations as this technology develops. PBM wavelengths can induce varied biological effects in diverse skin types, races, and ethnicities; therefore, it is also important for dermatologists to properly counsel their skin of color patients who undergo PBM treatments. Future clinical trials are necessary to produce standardized recommendations across conditions and skin types.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Mineroff J, Maghfour J, Ozog DM, et al. Photobiomodulation CME part II: Clinical applications in dermatology. J Am Acad Dermatol. 2024. PMID: 38307144. doi:10.1016/j.jaad.2023.10.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。